Prediction and benefit system of adyuvante chemotherapy for gastric cancer patients in the second and third stadiums

摘要

The current invention is a system for predicting the prediction and benefits of adyuvante chemotherapy in patients with gastric cancer of grade II and III, An algorithm was developed to predict the prediction and response of chemotherapy, and the quantitative analysis results of gene marker groups and a group of advanced gastric cancer reference genes related to the prediction or response of chemotherapy were used, It can be used as supplementary information to determine the treatment of gastric cancer.